Format

Send to

Choose Destination
Crit Rev Oncog. 2012;17(2):123-43.

Anaplastic lymphoma kinase in human cancer.

Author information

1
Department of Molecular Biology, Umea University, Umea, Sweden.

Abstract

The anaplastic lymphoma kinase (ALK) receptor tyrosine kinase is now implicated in a wide range of human cancers. Results from recent clinical trials with ALK inhibitors provide promise for patients harboring oncogenic ALK lesions. This review will discuss our current understanding of ALK in human cancer and the implication of recent results for treatment.

PMID:
22471704
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for BegellHouse Publisher, Inc.
Loading ...
Support Center